CSRXP: ANALYSIS FINDS 200 PERCENT INCREASE IN SECONDARY PATENT FILINGS AS BIG PHARMA EXPLOITS LOOPHOLES TO BLOCK COMPETITION
Over 15 Year Period, Brand Name Drug Companies Increasingly Filed for… Read More
Over 15 Year Period, Brand Name Drug Companies Increasingly Filed for… Read More
Brand Name Drug Companies Barrel Ahead with Business-As-Usual Approach to… Read More
Lawmakers Should Focus on Bipartisan Solutions to Hold Big Pharma Accountable,… Read More
U.S. Senate HELP Committee Should Advance Legislation to Boost Competition and… Read More
Nearly 500 Percent Price Increase on Vaccine Developed with Taxpayer… Read More
Bipartisan Transparency Legislation Will Help Hold Big Pharma Accountable for… Read More
Senate HELP Committee Hearing with Moderna CEO Offers Prime Opportunity to… Read More
More Big Pharma Companies Should Also Lower Their Insulin Prices… Read More
Senate Judiciary Committee Advances Critical Legislation to Crack Down on… Read More
Policies Must Address Big Pharma’s Egregious Practices That Cause High Drug… Read More
Comment Letters Highlight Key Agency Initiatives Targeting Brand Name Drug… Read More
Broad Majorities Reject Big Pharma’s Blame Game and Want Policymakers to… Read More